Cite Filings / AMRX / 9999999995-23-003318

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Amneal Pharmaceuticals, Inc. Filed 2023-11-14 Acc 9999999995-23-003318

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2023-11-14 EFFECT Notice of Effectiveness
2023-11-14 EFFECT Notice of Effectiveness
2023-11-14 8-K Material agreement · New debt or obligation
2023-11-09 10-Q Quarterly Report
2023-11-08 4 10% owner acquired 53,578,209 shares (other)
2023-11-08 4 Director acquired 17,497,336 shares (other)
2023-03-24 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…